N/A
N=10
Dermatosis Papulosa Nigra
Facial Dermatoses · Seborrheic Keratoses
Bottom Line
View on ClinicalTrials.gov: NCT00710203 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2014
Primary outcome: Primary: Percent Clearance of All Lesions — 88; 96; 92.5; 0 percentage of lesion clearance
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pulsed dye laser (Device); Curettage (Procedure); Electrodesiccation (Procedure); No treatment (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, Davis
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Clearance of All Lesions |
88; 96; 92.5; 0 | — |
Summary
DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face.
The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).
Eligibility Criteria
Inclusion Criteria
- Over 18 years of age.
- Able to give informed consent.
- Desires removal of lesions.
- Willing to come back for six week follow-up.
- Willing to fill out post operative questionnaire.
- At least 4 lesions less than 7 mm.
- Diagnosis of Dermatosis Papulosa Nigra (DPN)
Exclusion Criteria
- Less than 18 years of age.
- Pregnant.
- Sensitive to laser energy.
- History of Collagen Vascular Disorders.
- History of Keloids.
- History of post inflammatory hyperpigmentation.
- Incarcerated.
- Unable to give informed consent.
- Unable to follow up for post operative evaluation.
- Unable to complete patient visual analogue scale.
- Unable to understand consent process or risks.
- Unable to accept risk of scar, infection, minor bleeding, permanent or prolonged hyperpigmentation and hypopigmentation.
Data sourced from ClinicalTrials.gov (NCT00710203). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.